Researchers can watch drug activity in a molecule (w/ Video)

February 17, 2010

( -- Weill Cornell's Scott Blanchard has developed technology that can observe drug activity in a solitary molecule while in motion. The development may lead to newer, safer drug therapies.

That means that, for first time, researchers can see how molecular movements are affected by antibiotic binding. The findings, which are published in the March issue of (6:3), may lead to the development of new drug therapies.

"Understanding molecular movements is important because function hinges on motion," said Scott Blanchard, senior author and associate professor of physiology and biophysics at WCMC. "To observe the molecule, we are decorating it with fluorescent markers, called fluorophores, that make it glow."

This video is not supported by your browser at this time.

The fluorophores are attached to the biomolecule and are designed to exchange energy with each other in a way that accurately reports on the distance between them, like a molecular global positioning system. This process is called . When applied to the study of single-molecules, one can actually use this technique to monitor changes in the structure of individual enzymes as they function.

Traditionally, to understand how drugs affect enzymes, researchers have measured changes in the rate at which an enzyme generates product, which often requires a great deal of starting material. The new single-molecule approach provides the ability to observe enzyme function from the perspective of motion, and how such motions are influenced by the presence of substrates or drug compounds.

In the current study, Blanchard and his team investigated whether the binding of aminoglycoside-class antibiotics -- an important family of clinically useful small-molecule compounds -- affects how the ribosome moves. The ribosome, one of the largest and most essential molecular machines in the cell, is the target of almost half of all known antibiotics currently in use.

The aminoglycosides, while highly effective, tend to be toxic. Blanchard's goal was to explore the relationship between aminoglycoside activities and movements and to search for compounds with more potent activities but that have fewer side effects.

While the approach has many advantages, one of the most valuable is that it is "green," said Blanchard. As implied by its name, single-molecule methods are characterized by a greatly reduced demand for biological material. Consequently, less human and capital costs go into large-scale sample preparations. In principle, the researchers believe the single-molecule technique may one day be engineered to require a million times less starting material than is required by traditional drug screening methods.

"In addition to this material advantage, the information content of the single-molecule approach is greater, increasing the cost effectiveness of each experiment," said Blanchard. "Our challenge now is to understand whether the approach is generalizable to other enzyme systems where an understanding of its regulation and the mechanism of drug action are lacking."

Explore further: Unlocking the function of enzymes

Related Stories

Unlocking the function of enzymes

November 6, 2007

Fitting a key into a lock may seem like a simple task, but researchers at Texas A&M University are using a method that involves testing thousands of keys to unlock the functions of enzymes, and their findings could open the ...

New computational technique can predict drug side effects

December 11, 2007

Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.

Recommended for you

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Moonlighting molecules: Finding new uses for old enzymes

November 27, 2015

A collaboration between the University of Cambridge and MedImmune, the global biologics research and development arm of AstraZeneca, has led researchers to identify a potentially significant new application for a well-known ...

Atom-sized craters make a catalyst much more active

November 24, 2015

Bombarding and stretching an important industrial catalyst opens up tiny holes on its surface where atoms can attach and react, greatly increasing its activity as a promoter of chemical reactions, according to a study by ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.